12 Sep Community Cancer Play OneOncology Launches with $200M From General Atlantic
By Marek Zipkin
OneOncology Inc. (Nashville, Tenn.) launched on Wednesday, backed with more than $200 million from General Atlantic that the newco will use to develop a data and technology platform to support community-based cancer care.
On a conference call, Tracy Bahl, CEO and president of OneOncology, said the growing need for ongoing care in treating cancer makes adherence more difficult due to the travel often required to oncology centers, thus pushing patients to seek treatment through community care in increasing numbers. He added that the pace of change in standard of care, regulation and payment can be overwhelming for small practices.
OneOncology aims to address the needs of community oncologists with a platform, developed by the Flatiron Health subsidiary of Roche (SIX:ROG; OTCQX:RHHBY), that utilizes scale and access to data to keep costs low while improving quality of care to levels found at institutions, said Bahl. Tennessee Oncology, New York Cancer and Blood Specialists and the University of Tennessee’s West Cancer Center — community practices with ownership stakes in OneOncology — will link about 225 oncologists in 60 locations.
Bahl was EVP of health plans at CVS Health Corp. (NYSE:CVS) before joining OneOncology.